Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 4/20 | 0.35 |
| ▸ | DRD3 | P35462 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.33 |
| ▸ | DRD4 | P21917 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30256722 | 0.87 | DRD3 (0.32) | DRD2DRD3SLC6A3DRD4 | |
| SCHEMBL16113703 | 0.85 | KMT2A (0.38) | TDP1DRD2DRD3ALDH1A1SLC6A3 | |
| SCHEMBL30181736 | 0.82 | — | — | |
| SCHEMBL13833151 | 0.81 | DRD2 (0.47) | DRD2DRD3SLC6A3DRD4MEN1 | |
| SCHEMBL8860654 | 0.81 | DRD2 (0.47) | DRD2DRD3SLC6A3DRD4MEN1 | |
| SCHEMBL5860445 | 0.81 | — | — | |
| SCHEMBL17996818 | 0.81 | DRD2 (0.47) | DRD2DRD3SLC6A3DRD4MEN1 | |
| SCHEMBL636364 | 0.81 | DRD2 (0.47) | DRD2DRD3SLC6A3DRD4MEN1 | |
| SCHEMBL3970694 | 0.81 | DRD2 (0.47) | DRD2DRD3SLC6A3DRD4MEN1 | |
| SCHEMBL24615931 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179035-A1 | METHOD FOR PREPARING A REACTION PRODUCT, COMPOSITIONS INCLUDING THE REACTION PRODUCT, AND USES OF THE REACTION PRODUCT | THE LUBRIZOL CORPORATION (US) | 2025-06-05 | — | — | US | claimed |
| CN-118843623-A | Method for producing a reaction product containing 3,3' -methylenebis [ 5-methyl oxazolidine ], a composition comprising the reaction product and the use of the reaction product | 路博润公司 | 2024-10-25 | — | — | CN | claimed |
| WO-2024115457-A1 | HEAT-TRANSFER FLUIDS WITH LOW ELECTRICAL CONDUCTIVITY COMPRISING HYDROXYLAMINE OR OXIME FUNCTIONALITY, METHODS FOR THEIR PREPARATION AND USES THEREOF | Arteco N.v. (BE) | 2024-06-06 | — | — | WO | claimed |
| CN-117660096-A | High-lubrication metal alloy total-synthesis cutting fluid and preparation method thereof | 东莞市新美达材料技术有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-20240058243-A1 | A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES | SYMRISE AG (DE) | 2024-02-22 | — | — | US | claimed |
| EP-4316243-A1 | A PRESERVATION METHOD | BRAIN Biotech AG (DE) | 2024-02-07 | — | — | EP | claimed |
| EP-4316461-A1 | A PRESERVATIVE COMPOSITION | BRAIN Biotech AG (DE) | 2024-02-07 | — | — | EP | claimed |
| EP-4316459-A1 | A PRESERVATIVE COMPOSITION | BRAIN Biotech AG (DE) | 2024-02-07 | — | — | EP | claimed |
| EP-3512924-B1 | USE OF COMPOSITIONS HAVING A CONTENT OF CONDENSATION PRODUCT OF 1-AMINOPROPAN-2-OL AND FORMALDEHYDE IN THE REMOVAL OF SULPHUR COMPOUNDS FROM PROCESS STREAMS | VINK CHEMICALS GMBH & CO KG (DE) | 2023-12-27 | — | — | EP | claimed |
| CN-117106505-A | Performance regulator for industrial fluid | 上海森帝润滑技术有限公司 | 2023-11-24 | — | — | CN | claimed |
| EP-1512323-B1 | Microbicidal composition based on formaldehyde donor compounds and antioxidants | AIR LIQUIDE SANTE INT (FR) | 2007-02-21 | — | — | EP | claimed |
| US-20060223806-A1 | Microbicidal composition based on formaldehyde donor compounds and antioxidants | SCHULKE & MAYR GMBH (DE) | 2006-10-05 | — | — | US | claimed |
| EP-1679360-A1 | Use of formaldehyde and formaldehyde-releasing compounds in a composition for controlling mycobacteria | AIR LIQUIDE SANTE (INTERNATIONAL) (FR) | 2006-07-12 | — | — | EP | claimed |
| US-20060142291-A1 | Use of formaldehyde and formaldehyde-releasing compounds in a composition for controlling mycobacteria | AIR LIQUIDE SANTE (INTERNATIONAL) (FR) | 2006-06-29 | — | — | US | claimed |
| US-20050218379-A1 | Low-emission formaldehyde donor preparations | SCHULKE & MAYR GMBH (DE) | 2005-10-06 | — | — | US | claimed |
| EP-1579763-A2 | Low-emission formaldehyde depot composition | Air Liquide Santé (International) (FR) | 2005-09-28 | — | — | EP | claimed |
| US-20050054642-A1 | Microbicidal composition based on formaldehyde donor compounds and antioxidants | SCHULKE & MAYR GMBH (DE) | 2005-03-10 | — | — | US | claimed |
| EP-1512323-A1 | Microbicidal composition based on formaldehyde donor compounds and antioxidants | Air Liquide Santé (International) (FR) | 2005-03-09 | — | — | EP | claimed |
| US-20040082473-A1 | A formal, especially a hemiformal, and emission-reducing additive which is urea, urea derivative, amino acid, guanidine or guanidine derivative; contains no iodopropynyl compound or 1H-benzimidazol-2-carbamic acid derivative | SCHULKE & MAYR GMBH (DE) | 2004-04-29 | — | — | US | claimed |
| EP-1402778-A1 | Low-emission formaldehyde donor preparations and use thereof | Air Liquide Santé (International) (FR) | 2004-03-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240058243-A1 | A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES | MGLL, GCDH, GK | TSHR 3744/4885TDP1 3018/4885DRD2 1319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.